VBC106 for advanced solid tumors that have stopped responding to treatment
Part of Cancer clinical trials.
This trial tests a new drug called VBC106 in people with advanced solid tumors that have grown despite standard treatments. The goal is to see if the drug can shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid tumor that has not responded to standard treatments or you cannot tolerate them.
- You have at least one measurable tumor that can be assessed with imaging.
- You are 18 years or older, with a good performance status (able to care for yourself).
- Your heart function is within a certain range, and you do not have severe heart disease.
- You have a tumor tissue sample available or can provide a fresh biopsy.
- You have adequate organ and bone marrow function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, VBC103, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink or slow the growth of these tumors.
This trial tests a new drug called VBC101 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if VBC101 is safe and effective.
This trial tests a new drug, BTM-3566, for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
This trial tests an experimental drug called VBC108 in people with advanced solid tumors that have not responded to other treatments. The study aims to see if the drug is safe and effective.
This trial tests a new experimental drug (called VBC117) for people with advanced solid tumors that have spread. The drug is a type of targeted therapy that seeks out cancer cells and delivers a chemotherapy-like payload directly to them. The study aims to find the best dose and see if it is safe and effective.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Participants With Advanced Solid Tumor Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.